Israel - Inggris - Ministry of Health

teva israel ltd - olanzapine - tablets orodispersible - olanzapine 5 mg - olanzapine - acute and maintenance treatment of schizophrenia. olanza odt teva is indicated for the management of the manifestations of psychotic disorders.olanza odt teva is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder. prevention of recurrence in bipolar disorder : in patients whose manic episode has responded to olanzapine treatment olanza odt teva is indicated for the prevention of recurrence in patients with bipolar disorder. combination therapy in bipolar i disorder: the combination of olanza odt teva with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder.

Israel - Inggris - Ministry of Health

teva israel ltd - atazanavir as sulfate - capsules - atazanavir as sulfate 150 mg - atazanavir - atazanavir teva ® is indicated in combination with other antiretroviral agents for for the treatment of hiv-1 infection.

Israel - Inggris - Ministry of Health

teva israel ltd - imatinib as mesylate - film coated tablets - imatinib as mesylate 100 mg - imatinib - for the treatment of adult patients and children 3 years of age and above with ph+ chronic myeloid leukaemia(ph+ -cml) in chronic phase accelerated phase or blast crisis.imatinib teva is also indicated for the treament of :adult patients with newly diagnosed philadelphia chromosome positive acute lymphoblastic leukemia (ph+all) integrated with chemotherapy.adult patients with relapsed or refractory ph + all as monotherapy.adult patients with unresectable dermatofibrosarcoma protuberans (dfsp) and adult patients with recurrent and/or metastatic dfsp who are not eligible for surgery.adult patients with myelodyspiastic/myeloproliferative diseases (mds/mpd) associated with pdgfr ( platelet - derived growth factor receptor ) gene re- arrangements.adult patients with hypereosinophilic syndrome (hes) and/or chronic eosinophilic leukaemia (cel) who have the fip1l1- pdgfralfa fusion kinase (mutational analysis or fish demonstration fo chic2 allele deletion) and for patients with hes and/or cel who are fip1l1-pdgfr alfa fusion kinase negative .adult patients with aggressive systemic mastocytosis (asm) without the d816v c-kit mutation.imatinib teva is also indicated for the treatment of adult patients with kit (cd117) positive unresectable and/or metastatic malignant gastrointestinal stromal tumours (gist)imatinib teva is also indicated for adjuvant treatment of adult patients following complete gross resection of kit (cd117) positive gist.

Israel - Inggris - Ministry of Health

teva israel ltd - imatinib as mesylate - film coated tablets - imatinib as mesylate 400 mg - imatinib - for the treatment of adult patients and children 3 years of age and above with ph+ chronic myeloid leukaemia(ph+ -cml) in chronic phase accelerated phase or blast crisis.imatinib teva is also indicated for the treament of :adult patients with newly diagnosed philadelphia chromosome positive acute lymphoblastic leukemia (ph+all) integrated with chemotherapy.adult patients with relapsed or refractory ph + all as monotherapy.adult patients with unresectable dermatofibrosarcoma protuberans (dfsp) and adult patients with recurrent and/or metastatic dfsp who are not eligible for surgery.adult patients with myelodyspiastic/myeloproliferative diseases (mds/mpd) associated with pdgfr ( platelet - derived growth factor receptor ) gene re- arrangements.adult patients with hypereosinophilic syndrome (hes) and/or chronic eosinophilic leukaemia (cel) who have the fip1l1- pdgfralfa fusion kinase (mutational analysis or fish demonstration fo chic2 allele deletion) and for patients with hes and/or cel who are fip1l1-pdgfr alfa fusion kinase negative .adult patients with aggressive systemic mastocytosis (asm) without the d816v c-kit mutation.imatinib teva is also indicated for the treatment of adult patients with kit (cd117) positive unresectable and/or metastatic malignant gastrointestinal stromal tumours (gist)imatinib teva is also indicated for adjuvant treatment of adult patients following complete gross resection of kit (cd117) positive gist.

Israel - Inggris - Ministry of Health

teva israel ltd - icatibant as acetate - solution for injection - icatibant as acetate 30 mg / 3 ml - icatibant - icatibant teva is indicated for symptomatic treatment of acute attacks of hereditary angioedima (hae) in adults, adolescents and children aged 2 years and older, with c1-esterase-inhibitor deficiency.

Israel - Inggris - Ministry of Health

teva israel ltd - emtricitabine; tenofovir disoproxil as fumarate - film coated tablets - emtricitabine 200 mg; tenofovir disoproxil as fumarate 245 mg - tenofovir disoproxil - emtrivir teva is indicated in combination with other anti-retroviral medicinal products for the treatment of hiv-1 infected adults over 18 years of age.emtrivir teva® is indicated in combination with safer sex practices for pre-exposure prophylaxis to reduce the risk of sexually acquired hiv-1 infection in adults at high risk.

Israel - Inggris - Ministry of Health

teva israel ltd - diazepam - solution for injection - diazepam 10 mg / 2 ml - diazepam - symptomatic relief of tension and anxiety either alone or when associated with stressful situations. psychoneurotic states manifested by tension, anxiety, apprehension, fatique and depressive symptoms.in acute alcohol withdrawal, assival teva may be useful in the symptomatic relief of tremor, impending or acure delirium tremens and hallucinosis. assival teva is a useful adjunct in the relief of skeletal muscle spasms, spasticity, stiffman syndrome and tetanus. when used intravenously, assival teva injection is a useful adjunct in status epilepticus and severe recurrent convulsive seizures. as premedication in patients undergoing surgical procedures (the intramuscular route is preferred) or in patients undergoing cardioversion(when the intravenous route is preferred).

Israel - Inggris - Ministry of Health

teva israel ltd - bortezomib - powder for solution for injection - bortezomib 3.5 mg - bortezomib - bortezomib teva is indicated for the treatment of patients with multiple myeloma. bortezomib teva is indicated for the treatment of patients with mantle cell lymphoma who have received at least one prior therapy. bortezomib teva in combination with rituximab, cyclophosphamide, doxorubicin and prednisone is indicated for the treatment of adult patients with previously untreated mantle cell lymphoma who are unsuitable for haematopoietic stem cell transplantation

Israel - Inggris - Ministry of Health

teva pharmaceutical industries ltd, israel - duloxetine as hydrochloride - capsules - duloxetine as hydrochloride 60 mg - duloxetine - duloxetine dr teva is indicated for:- the treatment of major depressive episodes. - the management of neuropathic pain associated with diabetic peripheral neuropathy. - the treatment of generalized anxiety disorder (gad).- the management of fibromyalgia. - the management of chronic muscoskeletal pain when other therapies have failed or are contra-indicated. this has been established in studies in patients with chronic low ‎back pain (clbp) and chronic pain due to osteoarthritis.

Israel - Inggris - Ministry of Health

teva pharmaceutical industries ltd, israel - duloxetine as hydrochloride - capsules - duloxetine as hydrochloride 30 mg - duloxetine - duloxetine dr teva is indicated for:- the treatment of major depressive episodes. - the management of neuropathic pain associated with diabetic peripheral neuropathy. - the treatment of generalized anxiety disorder (gad).- the management of fibromyalgia. - the management of chronic muscoskeletal pain when other therapies have failed or are contra-indicated. this has been established in studies in patients with chronic low ‎back pain (clbp) and chronic pain due to osteoarthritis.